Litigation Details for TAKEDA PHARMACEUTICAL COMPANY LIMITED v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2018)
✉ Email this page to a colleague
TAKEDA PHARMACEUTICAL COMPANY LIMITED v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-07-18 |
| Court | District Court, D. New Jersey | Date Terminated | 2021-08-18 |
| Cause | 35:271 Patent Infringement | Assigned To | Freda L. Wolfson |
| Jury Demand | Defendant | Referred To | Tonianne J. Bongiovanni |
| Patents | 6,328,994; 7,431,942; 7,875,292 | ||
| Link to Docket | External link to docket | ||
Details for TAKEDA PHARMACEUTICAL COMPANY LIMITED v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2022-05-18 | 111 | Opinion | violated three Takeda patents, including U.S. Patent No. 6,328,994 (the “’994 Patent”), which was issued…the earlier ’994 [Patent], ’942 [Patent], and [U.S. Patent No. 7,875,292 (“’292 Patent”)].” Id. at 13–15…, ’546 Patent col. 37 ll. 37–40. Unlike Claim 1 of the ’994 Patent, Claim 1 of the ’546 Patent does not…of the ’546 Patent. “It is a ‘bedrock principle’ of patent law that ‘the claims of a patent define the… See ECF No. 76-5, ’994 Patent. 2 As relevant here, Claim 1 of the ’994 Patent recites: An orally | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
